Indoleamine 2, 3-dioxygenase (IDO) inhibitors and cancer immunotherapy

Y Fujiwara, S Kato, MK Nesline, JM Conroy… - Cancer treatment …, 2022 - Elsevier
Strategies for unlocking immunosuppression in the tumor microenvironment have been
investigated to overcome resistance to first-generation immune checkpoint blockade with …

Targeted therapy and mechanisms of drug resistance in breast cancer

B Kinnel, SK Singh, G Oprea-Ilies, R Singh - Cancers, 2023 - mdpi.com
Simple Summary Internationally, in women, breast cancer (BC) is the most common cancer
type and is the leading cause of cancer-related death. There are two main histological …

Functions of the aryl hydrocarbon receptor (AHR) beyond the canonical AHR/ARNT signaling pathway

NC Sondermann, S Faßbender, F Hartung… - Biochemical …, 2023 - Elsevier
The aryl hydrocarbon receptor (AHR) is a ligand-dependent transcription factor regulating
adaptive and maladaptive responses toward exogenous and endogenous signals …

The role of the aryl hydrocarbon receptor (AhR) and its ligands in breast cancer

S Safe, L Zhang - Cancers, 2022 - mdpi.com
Simple Summary The aryl hydrocarbon receptor (AhR) is expressed in breast cancer cells
and tumors and in some studies, the AhR is a negative prognostic factor for patient survival …

Tumor-suppressive functions of the aryl hydrocarbon receptor (AhR) and AhR as a therapeutic target in cancer

DJ Elson, SK Kolluri - Biology, 2023 - mdpi.com
Simple Summary Cancer is driven by the excessive activity of growth-promoting genes and
deficient activity of the genes that restrain cell growth. Genes that suppress cell growth …

Environmental exposure and the role of AhR in the tumor microenvironment of breast cancer

C Sweeney, G Lazennec, CFA Vogel - Frontiers in Pharmacology, 2022 - frontiersin.org
Activation of the aryl hydrocarbon receptor (AhR) through environmental exposure to
chemicals including polycyclic aromatic hydrocarbons (PAHs) and polychlorinated dibenzo …

[HTML][HTML] Unraveling the differential impact of PAHs and dioxin-like compounds on AKR1C3 reveals the EGFR extracellular domain as a critical determinant of the AHR …

C Vogeley, NC Sondermann, S Woeste… - Environment …, 2022 - Elsevier
Polycyclic aromatic hydrocarbons (PAHs), dioxin-like compounds (DLCs) and structurally-
related environmental pollutants may contribute to the pathogenesis of various diseases and …

Camalexin, an indole phytoalexin, inhibits cell proliferation, migration, and mammosphere formation in breast cancer cells via the aryl hydrocarbon receptor

N Yamashita, C Taga, M Ozawa, Y Kanno… - Journal of natural …, 2022 - Springer
Breast cancer is the most commonly diagnosed cancer among women worldwide. Despite a
variety of drugs available for the treatment of patients with breast cancer, drug resistance …

Unveiling the mechanistic role of the Aryl hydrocarbon receptor in environmentally induced Breast cancer

P Chatterjee, S Banerjee - Biochemical Pharmacology, 2023 - Elsevier
The aryl hydrocarbon receptor (AhR) is a crucial cytosolic evolutionary conserved ligand-
activated transcription factor and a pleiotropic signal transducer. The biosensor activity of the …

Aryl hydrocarbon receptor: An emerging player in breast cancer pathogenesis and its potential as a drug target

C Chen, Z Wang, Z Liao, Y Zhang… - Molecular …, 2023 - spandidos-publications.com
Breast cancer is the most common malignancy in women. Metastatic breast cancer is
incurable and is a major cause of shortened patient survival. The different molecular types of …